Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID-19 pandemic in China: a qualitative study. by Sun, Yinghui et al.
Sun et al. Journal of the International AIDS Society 2021, 24:e25781
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25781/full | https://doi.org/10.1002/jia2.25781
RESEARCH ARTICLE
Stakeholder efforts to mitigate antiretroviral therapy interruption
among people living with HIV during the COVID-19 pandemic in
China: a qualitative study
Yinghui Sun1 , Yuewei Zhan1 , Hui Li2 , Tanwei Yuan1 , Yanxiao Gao1 , Bowen Liang1 , Anping Feng1 ,
Peiyang Li1 , Weiran Zheng1, Thomas Fitzpatrick3 , Dan Wu4 , Xinyi Zhai5 and Huachun Zou1,6,7,§
§Corresponding author. Huachun Zou, 132 Waihuandong Rd, Sun Yat-sen University, Panyu District, Guangzhou, Guangdong, 511431, China.
Email: zouhuachun@mail.sysu.edu.cn
Yinghui Sun, Yuewei Zhan and Hui Li contributed equally to this work.
Abstract
Introduction: The COVID-19 pandemic has affected antiretroviral therapy (ART) continuity among people living with HIV
(PLHIV) worldwide. We conducted a qualitative study to explore barriers to ART maintenance and solutions to ART interrup-
tion when stringent COVID-19 control measures were implemented in China, from the perspective of PLHIV and relevant key
stakeholders.
Methods: Between 11 February and 15 February 2020, we interviewed PLHIV, community-based organization (CBO) work-
ers, staff from centres for disease control and prevention (CDC) at various levels whose work is relevant to HIV care (CDC
staff), HIV doctors and nurses and drug vendors from various regions in China. Semi-structured interviews were conducted
using a messaging and social media app. Challenges and responses relevant to ART continuity during the COVID-19 pandemic
were discussed. Themes were identified by transcript coding and mindmaps.
Results: Sixty-four stakeholders were recruited, including 16 PLHIV, 17 CBO workers, 15 CDC staff, 14 HIV doctors and
nurses and two drug vendors. Many CDC staff, HIV doctors and nurses responsible for ART delivery and HIV care were
shifted to COVID-19 response efforts. Barriers to ART maintenance were (a) travel restrictions, (b) inadequate communica-
tion and bureaucratic obstacles, (c) shortage in personnel, (d) privacy concerns, and (e) insufficient ART reserve. CBO helped
PLHIV maintain access to ART through five solutions identified from thematic analysis: (a) coordination to refill ART from local
CDC clinics or hospitals, (b) delivery of ART by mail, (c) privacy protection measures, (d) mental health counselling, and (e)
providing connections to alternative sources of ART. Drug vendors contributed to ART maintenance by selling out-of-pocket
ART.
Conclusions: Social and institutional disruption from COVID-19 contributed to increased risk of ART interruption among
PLHIV in China. Collaboration among key stakeholders was needed to maintain access to ART, with CBO playing an important
role. Other countries facing ART interruption during current or future public health emergencies may learn from the solutions
employed in China.
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living with HIV
Additional information may be found under the Supporting Information tab of this article.
Received 23 December 2020; Accepted 20 July 2021
Copyright © 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
1 INTRODUCT ION
Access and adherence to antiretroviral therapy (ART) is
needed for people living with HIV (PLHIV) to achieve viral
suppression, reduce HIV-associated morbidity and mortal-
ity, and prevent HIV transmission [1,2]. Over the last two
decades, China has made large strides in expanding access to
ART. In 2003 China adopted the ‘Four-Free One-Care’ policy,
under which all PLHIV in the country are able to access free
ART from designated healthcare facilities, including hospitals
specialized in infectious diseases and clinics affiliated to
centres for disease control and prevention (CDC) at various
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levels [3]. Thanks to this policy, the coverage of free ART
among diagnosed PLHIV in China increased from 64.2%
in 2006 to 86.6% in 2019 [4]. PLHIV who do not receive
government-subsidized ART often purchase medications
out-of-pocket at pharmacies or from drug vendors via the
internet [5].
HIV-themed community-based organizations (CBO) in
China provide health education, counselling, advocacy and
treatment monitoring services for PLHIV and people at risk
of HIV infection, including men who have sex with men
(MSM), sex workers, and people who inject drugs. From 1988
to 2009, the number of CBO working in the field of HIV
prevention and care in China increased from zero to over
400, with one-third and one-fourth of these organizations
focusing on the needs of MSM and PLHIV, respectively [6].
The number of CBO dedicated to HIV prevention and care
in China exceeded 700 in 2019 [7]. CBO play an important
role in promoting and connecting PLHIV and at-risk groups to
free health services, including HIV testing and ART [8].
To control the spread of COVID-19, China introduced a
series of public health responses. On 23 January 2020, a
citywide lockdown was imposed in Wuhan. On 26 January
2020, COVID-19 control measures were imposed nation-
wide [9]. Travel restrictions and suspension of postal services
were implemented across all 31 provinces and administrative
regions in mainland China. Citywide lockdowns and enforced
home quarantine were implemented in areas with confirmed
COVID-19 cases.
While China achieved significant success in containing
COVID-19, these measures also impeded the HIV care
services. To maintain access to ART, the National Center
for AIDS/STD Control and Prevention (NCAIDS) published
updated policy guidelines on 26 January 2020, which allowed
PLHIV to refill one-month of ART from any designated hospi-
tal or clinic [10]. Despite these efforts, more than one-third of
PLHIV in China reported risk of ART interruption at the early
stage of the COVID-19 outbreak [11]. PLHIV residing in areas
that implemented citywide lockdowns and travel restrictions
were at higher risk of ART interruption. Themes and theory
generated in qualitative study can explain and predict various
outcomes within diverse contexts of the healthcare system
[12,13]. However, to date, there is still a lack of qualitative
information on ART maintenance in the context of COVID-
19. To better characterize barriers to ART maintenance and
solutions to ART interruption in China during the implementa-
tion of stringent COVID-19 control measures, we conducted a
qualitative study among PLHIV and relevant key stakeholders.
2 METHODS
2.1 Study design and participants
Between 11 February and 15 February 2020, we interviewed
PLHIV and representatives from the following stakeholder
groups: CBO workers, CDC staff, HIV doctors and nurses, and
drug vendors [3,5,6]. Interviews were semi-structured and
designed based on discussions with a panel of eight experts in
the fields of ART delivery and HIV epidemiology. Participants
were recruited from all seven geographic regions of China,
including northern China (e.g., Beijing, Tianjin), eastern China
(e.g., Shanghai, Hefei), central China (e.g., Wuhan, Zhengzhou),
southern China (e.g., Shenzhen, Nanning), northwestern China
(e.g., Urumqi, Tianshui), southwestern China (e.g., Chongqing,
Chengdu) and northeastern China (e.g., Shenyang, Harbin).
Participants were selected by three HIV clinicians, one HIV
social worker and four HIV epidemiologists using purposive
sampling. Eligible participants were invited to complete an
interview via WeChat or telephone. Eligible PLHIV were at
least 18 years old and currently on ART. Eligible CBO work-
ers, CDC staff, HIV doctors and nurses, as well as drug ven-
dors were at least 18 years old and held a position related to
ART delivery. Study protocol is shown in the Supporting Mate-
rials in Additional file 1.
2.2 Data collection
Each interview was conducted online via WeChat, a mul-
tipurpose messaging and social media application (Tencent,
Shenzhen). Participants were allowed to be interviewed via
either a voice call or text messaging. Each interview was one-
on-one and lasted for approximately 20 minutes. Demographic
characteristics, including age, gender and geographic location,
were collected. PLHIV were asked about ART history, barriers
to obtaining ART in the midst of stringent COVID-19 control
measures and solutions to solve ART interruption. For this
study, the period of stringent COVID-19 control measures
was defined as 10 January 2020, when the Chinese New Year
holiday began and 15 February 2020, when our study ended.
Many PLHIV left the city where they typically accessed HIV
care during this period and were subsequently affected by
travel restrictions and home quarantine requirements. CBO
workers, CDC staff, HIV doctors and nurses, as well as drug
vendors were asked to describe their work conditions related
to ART delivery, barriers to ART delivery and solutions to
maintain HIV care during this period. Semi-structured inter-
view guides are available in Tables Figure S1-S5 in Additional
file 1 (Supporting Materials). Data collection was stopped
after thematic saturation was reached (i.e., when new data
produced little or no new information to address the study
question).
2.3 Data analysis
Voice calls were audio recorded, transcribed in Mandarin
and then encoded using NVivo 11.0 (QSR International, Mel-
bourne, Australia). Thematic analysis was used to analyse
and explore potential themes. We followed an analytical pro-
cess recommended by previous studies [14–16]: (a) famil-
iarizing yourself with your data, (b) generating initial codes,
(c) searching for themes, (d) reviewing themes, (e) defin-
ing and naming themes, and (f) producing the report. We
formed detailed codebooks for each of the five stakeholder
groups. An inductive approach was used to develop data-
driven themes. We applied two prespecified themes: (a) barri-
ers to ART maintenance, and (b) solutions to ART interruption.
We used a mindmap (see Figure S1 in Additional file 2) [17] to
summarize our prespecified themes before beginning the-
matic analysis. After discussion, we found CBO participated
in all identified aspects of barriers to ART maintenance and
solutions to ART interruption. Consequently, we refined and
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Figure 1. Joint efforts to mitigate ART interruption by CBO, PLHIV, CDC clinics, hospitals and drug vendors. ART, antiretroviral therapy;
CBO, community-based organizations; CDC, centres for disease control and prevention; PLHIV, people living with HIV.
renamed themes from the perspective of CBO. Consensus on
identified themes was reached after discussion. Descriptive
statistics were used to summarize demographic characteris-
tics. Informative quotations from participants were translated
to English and checked for accuracy. A relationship framework
among different stakeholders was generated to visually sum-
marize our results (Figure 1) [15].
After conducting inductive analysis in a data-driven way, we
performed higher order analysis based on the findings, aim-
ing to raise the generated themes to a conceptually theoreti-
cal level. We applied the theoretical framework based on the
Andersen’s Behavioral Model of Health Service Use (ABM)
[18], which is available to understand how patient and envi-
ronmental factors impact health behaviours and outcomes,
and has been applied in other qualitative studies about barri-
ers and facilitators of health programmes [19]. We combined
our results presented in Figure 1 with the ABM, to further
explore how patients and environmental factors affect ART
maintenance.
2.4 Ethical statement
This study was approved by the Sun Yat-sen University
Ethics Committee (SYSU-SPH2020008). Informed consent
was obtained from each participant prior to interview.
3 RESULTS
3.1 Characteristics of participants
Of 69 individual stakeholders invited, 64 (92.8%) completed
an interview, including 16 PLHIV, 17 CBO workers, 15 CDC
staff, 14 HIV doctors and nurses and two drug vendors.
Median age of PLHIV was 29 years (interquartile range (IQR):
24 to 37 years) and median duration since ART initiation was
2.5 years (IQR: 0.5 to 3.5 years). All CBO workers were men,
more than 50% of whom had worked in HIV care services for
over 10 years (IQR: six to twelve years) (Table 1). Among the
17 CBO workers we interviewed, 11 CBO provided services
to PLHIV exclusively and six provided services to both PLHIV
and MSM.
3.2 Barriers to ART maintenance
Despite NCAIDS policy guidelines designed to facilitate ART
maintenance during the COVID-19 pandemic, travel restric-
tions continued to have an impact on obtaining ART. Refill-
ing ART prescriptions was also impeded by inadequate com-
munication between PLHIV and HIV care facilities as well
as cumbersome bureaucratic processes. CDC staff, HIV doc-
tors and nurses struggled to balance their time between ART
delivery and COVID-19 response efforts. Some HIV doctors
and nurses were redeployed to respond to COVID-19 full-
time, leaving no time for ART delivery. For PLHIV, privacy
and unwanted disclosure of HIV status was a salient con-
cern when obtaining ART, particularly among those who were
unexpectedly forced to home quarantine with family mem-
bers. Insufficient ART reserve in CDC clinics and hospitals,
and among drug vendors, was a barrier to ART maintenance.
Detailed quotations are shown in Table 2.
3.3 CBO solutions to ART interruption
CBO played an important role in ART maintenance during
the COVID-19 pandemic. Specifically, CBO provided PLHIV
with guidance and coordination to refill ART, mail and home
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Table 1. Characteristics of participants
PLHIV (n = 16) CBO workers (n = 17)
HIV doctors and
nurses (n = 14) CDC staff (n = 15) Drug vendors (n = 2)
Gender
Men 14 (87.5%) 17 (100.0%) 3 (21.4%) 8 (53.3%) 2 (100.0%)
Women 2 (12.5%) 0 (0.0%) 11 (75.6%) 7 (46.7%) 0 (0.0%)
Age (years),
(median, IQR)
29.0 (24.0 to 37.0) 38.0 (32.0 to 45.0) 41.0 (35.0 to 49.0) 39.0 (34.5 to 48.5) -
Years on ART
(median, IQR)
2.5 (0.5 to 3.5)a - - - -
Years at work
(median, IQR)
- 10.0 (6.0 to 12.0)b 9.5 (4.0 to 12.5) 10.5 (5.3 to 15.0) -
Geographical distribution
Northern China 1 (6.3%) 3 (17.6%) 1 (7.1%) 2 (13.3%) 1 (50.0%)
Eastern China 5 (31.3%) 4 (23.5%) 2 (14.3%) 5 (33.3%) 1 (50.0%)
Central China 8 (50.0%) 3 (17.6%) 0 (0.0%) 2 (13.3%) 0 (0.0%)
Southern China 1 (6.3%) 3 (17.6%) 4 (28.6%) 2 (13.3%) 0 (0.0%)
Northwestern
China
1 (6.3%) 2 (11.8%) 0 (0.0%) 3 (20.0%) 0 (0.0%)
Southwestern
China
0 (0.0%) 0 (0.0%) 3 (21.4%) 1 (6.7%) 0 (0.0%)
Northeastern
China
0 (0.0%) 2 (11.8%) 4 (28.6%) 0 (0.0%) 0 (0.0%)
Abbreviations: ART, antiretroviral therapy; CBO, community-based organization; CDC, centres for disease control and prevention; IQR,
interquartile range; PLHIV, people living with HIV.
aOne missing
bOne missing.
delivery services, assistance in privacy protection, mental
health counselling and connections to alternative sources of
ART. Furthermore, CBO assisted CDC clinics and hospitals by
coordinating ART delivery to PLHIV.
3.3.1 Coordination to refill ART from local CDC
clinics or hospitals
While the NCAIDS directive allowed PLHIV to refill ART from
any HIV care facility in China, the specific process was initially
unclear to both PLHIV and healthcare providers. CBO played
an intermediary role by guiding PLHIV in their attempts to
refill ART. They referred PLHIV to online guidelines, helped
PLHIV contact local CDC clinics and hospitals and shared
experiences with other CBO.
I knew about the [NCAIDS policy], so I contacted my
local CDC clinic and infectious diseases hospital that
manages ART and asked for details about the policy,
but honestly speaking they were not clear on the policy
themselves and could only point to the policy document
itself. So, we disseminated the specifics on policies [to
obtain ART during the COVID-19 pandemic] through
our WeChat account, and bit by bit some PLHIV suc-
cessfully refilled ART from local CDC clinics and treat-
ment centres using these policies. Then we collected
their successful experiences and immediately shared
them with the rest of the service community. (CBO, No.
2, 35-year-old man, Hefei)
For PLHIV who did not know how to contact CDC clinics or
hospitals, CBO contributed by finding and providing contact
information.
[PLHIV] needed their designated hospital to provide a
work letter, but many PLHIV do not know the phone
number of their designated hospital. I found the number
for them, then they could contact their designated hos-
pitals, and a nurse would provide them with the needed
documentation. (CBO, No. 13, 56-year-old man, Tianjin)
3.3.2 Delivery of ART by mail
In-person ART collection was limited by travel restrictions
during the COVID-19 pandemic, so mail delivery became a
major source for ART refills for PLHIV in China. Because CDC
staff, HIV doctors and nurses were overwhelmed by COVID-
19 work, CBO workers became responsible for obtaining ART
and mailing it to PLHIV.
Some hospitals did not offer ART delivery through mail.
When PLHIV provided their information, we could go to
the hospital to collect their ART, and then assisted the
hospital in mailing ART to them. (CBO, No. 7, 38-year-
old man, Nanning)
Although public transportation was closed or suspended in
many locations, hospitals still tried to deliver ART to PLHIV
with the help of CBO.
[We] tried our best to send [ART] to PLHIV through
CBO. For example, if ground mail wasn’t possible, we’d
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Table 2. Barriers to ART maintenance from perspectives of different stakeholders
Barriers Quotations
Travel restrictions ‘Some (PLHIV) live in the countryside. They cannot leave and courier services cannot
reach them, so there is no solution’. (CBO, No.10, 40-year-old man, Zhengzhou)
‘Because the SF courier company would only deliver to towns and could not go
into the countryside because of road closures, a lot of rural PLHIV had to sneak
out of the countryside, walking for 40 kilometres, groping blindly in the dark [to
get ART]!’ (drug vendor, No. 2, man, Beijing)
Inadequate communication and bureaucratic
obstacles when attempting to refill ART
‘A [staff member at a local health facility] told me to ask the local CDC clinic for
help. Later, he told me to contact the AIDS prevention office, and then the health
bureau. After all that running back and forth I was still unable to solve my ART
problem’. (PLHIV, No. 6, 42-year-old woman, Baise)
‘The local CDC clinic has a lot of requirements, such as a letter from one’s
designated CDC clinic or hospital. It was difficult for people to track down the
chief of a CDC clinic or hospital [to obtain a letter], so most [PLHIV] chose not to
do this’. (CDC, No. 5, 36-year-old man, Guangzhou)
Shortage in personnel at HIV care facilities ‘[PLHIV] could not get in touch with local doctors responsible for ART delivery
because most doctors were mobilized to the front lines to fight the pneumonia
outbreak’. (CDC, No. 7, 46-year-old man, Xiaogan)
Privacy concerns of PLHIV ‘A particularly serious problem was that [PLHIV] who typically work outside their
hometowns had returned home to visit family members for Spring Festival. They
had to conceal from their family that they were taking ART, and also hide their
medications where no one would find them. They also worried whether regular
daily contact would infect family members. These problems created huge amounts
of stress for PLHIV, and some felt they were going to go crazy. They could not
leave due to home quarantine, but if they stayed their family would probably
discover they are infected, so it was incredibly stressful’. (CBO, No. 12,
54-year-old man, Cangzhou)
Insufficient reserve in CDC clinics and
hospitals and among drug vendors
‘Recently, the ART supply chain has been seriously disrupted, especially medications
in their original packaging, like TRIUMEQ and DTG (combination of dolutegravir,
abacavir and lamivudine), which are now out of stock across the country, no one
can buy them, because these medications do not come from India, but from South
Africa. In the past medications from South Africa were brought back by migrant
workers returning home to China, but this avenue is now totally cut-off’. (drug
vendor, No. 2, man, Beijing)
Abbreviations: ART, antiretroviral therapy; CBO, community-based organization; CDC, centres for disease control and prevention; PLHIV, people
living with HIV. In the quotations, ‘(...)’ represented the explanation of the former word/phrase in the original sentence, and ‘[...]’ represented
the contextual supplement to the missing sentence elements in the original sentence.
try air mail, or various courier companies, even if only
one method worked, we would still strive to send out
[ART]. (doctor, No. 8, 39-year-old man, Shenyang)
Because of travel restrictions and home quarantine, PLHIV
were unable to leave their towns or neighbourhoods to col-
lect ART. As a solution, some CBO workers physically deliv-
ered ART to PLHIV at their homes.
I am also a CBO worker, so I mobilized some of our vol-
unteers. When courier services could not reach a cer-
tain area, I would have CBO volunteers contact PLHIV,
and if the volunteers happened to live near a PLHIV,
they would drive over to the village pretending they
were dispensing food and deliver some ART, making
sure PLHIV could get ART in time. (doctor, No. 13, 48-
year-old man, Tieling)
Home delivery was an effective way to achieve ART main-
tenance, especially in places with strict citywide lockdowns or
home quarantines.
In Wuhan, there were volunteers and cars with travel
passes who would pick up [ART] and deliver it to vil-
lages and neighbourhoods, then [PLHIV] could come to
get ART themselves. (CBO, No. 16, 33-year-old man,
Shenzhen and Xiamen)
3.3.3 Privacy protection measures
Privacy was a major concern surrounding ART delivery. PLHIV
in China often do not disclose their HIV status to family mem-
bers. Due to home quarantine, many PLHIV were confined
at home with family members who did not know their HIV
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status. Stakeholders, including CBO workers, tried to protect
the privacy of PLHIV by removing labelling from ART, mailing
medications anonymously and mailing from home rather than
workplace addresses.
Most [PLHIV] asked us to remove all packaging from
the [ART], including labels. We are quite experienced at
this since clients have often asked us to help remove
medication labelling in the past. In this way even if fam-
ily members find a bottle of medication, there is nothing
for them to read. Some asked us to write a nickname
rather than their real name on the delivery packaging
because they were very worried that a neighbour might
see their name and say something to their family mem-
bers. Others asked us to specify on the delivery packag-
ing that the included item was a ‘daily necessity’ rather
than medication. (CBO, No. 15, 38-year-old man, Qing-
dao)
Mailing ART from a worker’s home address rather than the
CBO’s workplace address helped PLHIV protect their HIV sta-
tus from unwanted disclosure.
We did not mail ART from our workplace, because it is
inappropriate to write the name of our organization on
the delivery packaging. Instead, we mailed it from our
home address. (CBO, No. 1, 31-year-old man, Shenzhen)
3.3.4 Mental health counselling
At the time interviews were conducted, PLHIV had been quar-
antined at home for more than half a month. In addition to
fears about ART interruption, many also worried their HIV
status may place them at higher risk of critical illness from
COVID-19. PLHIV frequently mentioned secretly taking ART
at home and fears of inadvertently revealing their HIV sta-
tus to family members were sources of mental stress. To
respond to increasing rates of anxiety, depression and insom-
nia among PLHIV, CBO provided mental health counselling to
PLHIV through smartphone-based instant messaging applica-
tions.
Some (PLHIV) were anxious and irritable. We would use
periods of free time, like after 8 PM or 9 PM, to chat
with them via WeChat or QQ, and in the process pro-
vide some mental health counselling. (CBO, No. 12, 54-
year-old man, Cangzhou)
Some PLHIV did not seek mental health counselling even if
they had underlying mental illness. CBO took the initiative to
support this vulnerable group.
Of course, we would also actively find PLHIV who were
prone to depression. I would ask how they were doing
at home and give them some recommendations, such
as reading, listening to music and exercise, and through
these activities relieve the mental pressure of home
quarantine. (CBO, No. 15, 38-year-old man, Qingdao)
Although CBO could not guarantee a professional level
of mental health counselling, the emotional support of CBO
workers was important to PLHIV.
We could not provide professional counselling because
we are not professional counsellors or psychologists.
But we could still give general relief and comfort. (CBO,
No. 2, 35-year-old man, Hefei)
PLHIV reported CBO not only helped them by
coordinating with CDC clinics and hospitals, but also
encouraged them to persevere in efforts to obtain
ART.
I experienced ART interruption for six days and couldn’t
get any sleep. So I joined a chat group for PLHIV
who had experienced or were at risk of ART interrup-
tion due to the pandemic through an official account
and described my situation. A CBO worker added my
WeChat account to call me and ask about my wellbe-
ing. She also gave me the phone number to the director
of a local CDC clinic and explained my situation to the
director. The CDC clinic said I could borrow medicine
[from a local hospital] but could not arrange for delivery
of medicine. The CBO worker asked me about my situa-
tion every day and was more considerate than my doc-
tor. Every time I was about to give up, I remembered
how concerned the CBO was about me, and insisted
on getting my medicine. Finally, the CBO worker con-
tacted the pandemic response headquarters, and they
were willing to help me by contacting the local CDC
director and had them deliver medicine to me. Although
I had been off ART for nine days, after so many days of
hard work, I finally got my ART. The CBO worker and
I were very happy. When I told my friends the story,
they said it was incredible. I think this is the power of
persistence. I really want to thank the CBO. I also want
to thank the pandemic response headquarters staff who
answered the phone, the office director and the per-
son who drove me to get the medicine. Thank you all.
(PLHIV, No. 5, 29-year-old man, Xinjiang)
3.3.5 Providing connections to alternative sources of
ART
While CBO are typically not responsible for ART deliv-
ery in China, some do have small reserves of ART. Dur-
ing the COVID-19 pandemic, these ART reserves were
used to address ART interruption. ART reserves were typ-
ically collected through donations from PLHIV or larger
CBO.
ART reserves at CBO had been collected in normal
times. For instance, when patients changed their ART
prescription, they may have a half bottle of ART left,
which would be donated for others to use in an
emergency. CBO gradually accumulated ART over time,
which were all free medications. Other CBO might also
have extra ART that they could donate to us. (CBO, No.
12, 54-year-old man, Cangzhou)
As the pandemic continued, CBO ran out of free ART to
distribute. Buying ART out-of-pocket became an option for
some PLHIV to avoid ART interruption.
We also suggested some PLHIV purchase ART out-of-
pocket for a short period if they could not get free ART.
We would help them pick up ART after purchasing it
and mail it to them. But in the end this solution was
only appropriate for a small number of people because
most still need free medication. (CBO, No. 2, 35-year-
old man, Hefei)
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∙ Potential ART interruption risk
∙ Privacy protection
∙ Mental health counselling
Enabling factors ∙ Travel restrictions (home quarantine)
∙ Privacy concern of HIV status disclosure
∙ ART mail and home delivery
∙ Privacy protection
Perceived need ∙ Concerns of ART interruption




∙ Shortage in personnel at HIV care facilities
∙ Insufficient reserve (quantity/regimen/raw
material)
∙ ART reserve in CBO
∙ Out-of-pocket ART recommended by CBO and
bought from drug vendors
Clinic factors ∙ Bureaucratic obstacles ∙ Communication and coordination between PLHIV
and CDC clinics/hospitals (CBO)
∙ Counselling and guidance
Provider factors
∙ Inadequate communication
∙ Communication and coordination between PLHIV
and CDC clinics/hospitals (CBO)
∙ Counselling and guidance
External environment
External factors
∙ Travel restrictions (mail availability) ∙ Pick up ART for PLHIV from CDC clinics/hospitals
(CBO)
∙ ART mail and home delivery
Abbreviations: ABM, Andersen’s Behavioral Model; ART, antiretroviral therapy; CBO, community-based organization; CDC, centres for disease
control and prevention; PLHIV, people living with HIV.
3.4 Other solutions
Drug vendors also mitigated the risk of ART interruption by
selling ART to PLHIV who could afford out-of-pocket ART.
ART like Kocitaf (combination of dolutegravir, emtric-
itabine and tenofovir) have few side effects and are well
tolerated, so it is relatively safe to replace [free ART]
temporarily. (drug vendor, No. 2, man, Beijing)
Overall, stakeholders made significant contributions to
efforts to avoid interruption in ART during the COVID-19
pandemic. CBO acted as a bridge between PLHIV, CDC clin-
ics and hospitals. Figure 1 depicts the relationship among
stakeholders. Factors of patient and environment, both con-
tributed to barriers to ART maintenance and solutions to ART
interruption. And detailed analysis and description grouped by
ABM domains are given in Table 3.
4 D ISCUSS ION
This is one of the first qualitative studies of multiple stake-
holders to describe barriers to ART maintenance and solu-
tions to ART interruption during the COVID-19 pandemic
in China. Travel restrictions, inadequate communication and
bureaucratic obstacles between stakeholders, shortage in per-
sonnel, privacy concerns and insufficient ART reserve were
barriers to ART maintenance. CBO took on an important role
in responding to these barriers, acting as a bridge between
PLHIV and ART providers. CBO workers helped PLHIV navi-
gate bureaucratic requirements to refill ART from local CDC
clinics and hospitals. They also took on new responsibilities
during the COVID-19 pandemic, delivering ART to PLHIV
through the mail or in person, helping PLHIV protect their
HIV status from unwanted disclosure and providing mental
health counselling through social media applications.
We found that travel restrictions and home quarantine
measures made it difficult for some PLHIV in China to refill
ART from the designated CDC clinics or hospitals where
they typically receive HIV care. This finding is consistent with
large-scale nationwide surveys of PLHIV in China where risk
of ART interruption was correlated with travel away from
home and living in areas that implemented citywide lock-
downs during the COVID-19 pandemic [11]. Despite nation-
wide policy reform efforts by the Chinese central govern-
ment, PLHIV found local CDC clinics and hospitals to be slow
and inconsistent in operationalizing policies designed to mini-
mize the impact of COVID-19 control measures on HIV care.
CBO adopted new roles and novel measures to address these
barriers. CBO workers learned how to refill ART through any
local CDC clinic or hospital and then guided PLHIV through
bureaucratic obstacles. Peer navigation has been identified
as an important tool to optimize the HIV care continuum
[20] and became particularly important during the COVID-
19 pandemic. CBO coordination of ART mail and home deliv-
ery services also helped PLHIV in China avoid ART inter-
ruption when faced with restrictions on mobility. Similar
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strategies have been employed in other low- and middle-
income countries (LMICs) responding to disruptions in HIV
care from COVID-19, including the Philippines and Pakistan
[21–23]. Prior to the COVID-19 pandemic, home delivery of
ART by CBO was shown to improve early ART adherence
and outcomes [24], and during the COVID-19 pandemic this
strategy has been identified as key to maintaining ART access
in remote rural locations without reliable access to postal
services [23,25,26]. Many regions including America, Europe,
Asia and Africa benefited from CBO contributions to ART
delivery during the COVID-19 pandemic [25,27–30]. The role
of CBO in ART provision could be similarly expanded in other
low- and middle-income countries to optimize ART mainte-
nance. Efforts to maintain ART should take into consideration
variation and complexity among different settings and apply
suitable solutions in the country.
HIV-related stigma and fear of disclosure of HIV status
were common themes identified in our interviews of PLHIV
in China. Stigma has been identified as a significant barrier
to ART adherence in multiple contexts, and recent research
has shown home quarantine during the COVID-19 pandemic
can exacerbate its influence [1,31]. Many PLHIV in this study
were reluctant to take ART while quarantined at home or
apply for legal authorization to leave home to refill ART for
fear that family members, partners, friends or neighbours
would discover their HIV status. Delivery of ART by mail
was preferred by some PLHIV because it allowed for refills
to be obtained discretely. However, unwanted disclosure of
HIV status to household members through labelling on pack-
aging remained a concern identified in our interviews and
in previous research of PLHIV in China [31]. CBO workers
addressed this concern by removing identifying labels from
both packaging and medication bottles before delivering ART
to PLHIV in the mail or in person. CBO also provided a plat-
form for PLHIV in China to voice their anxiety about privacy
during home quarantine and solicit support from peers. Pre-
vious studies in other settings have highlighted the impor-
tance of addressing stigma among PLHIV through listening,
counselling and communication when providing HIV care and
ART [1,32,33]. Our findings also reflect challenges of stigma
in maintaining ART and underscore the importance of sus-
tained efforts to destigmatize HIV status and address PLHIV
marginalization worldwide, both during and after the COVID-
19 pandemic. Additionally, expediencies such as removing ART
label, anonymous mailing could help in privacy protection in
constrained settings of social inclusiveness, and increase the
ART adherence.
PLHIV in China reported increased anxiety, depression and
insomnia during the COVID-19 pandemic. Concerns regarding
increased risk of critical illness from COVID-19 infection and
difficulty in obtaining ART were commonly reported sources
of emotional stress in our interviews. Previous research
found disruption caused by COVID-19 has disproportionately
affected the mental health of PLHIV in China as well as inter-
nationally [30,31,34]. CBO have historically provided mental
health support to PLHIV in China, and these efforts were
strengthened during the COVID-19 pandemic. CBO work-
ers provided counselling services outside of normal business
hours, contacting clients at times when they could main-
tain privacy despite being quarantined at home with fam-
ily members. Social media platforms and mobile apps were
used to deliver counselling services to overcome barriers
imposed by travel restrictions and citywide lockdowns. Studies
in some high-income countries and LMICs have found emo-
tional support from CBO workers can help develop positive
attitudes and beliefs among PLHIV, contributing to improved
ART adherence [29,35–38]. Our results highlight that mental
health counselling could be one effective option to mitigate
mental stress and increase confidence to treatment among
vulnerable groups like PLHIV in countries with strict travel
restrictions.
Our study has several limitations. First, participants were
recruited through purposive sampling. China is a large coun-
try of 1.5 billion people with significant regional diversity in
terms of socio-economic conditions and HIV care services.
Consequently, our interviews may not represent the experi-
ences of PLHIV or stakeholders in the whole country. To max-
imize the representativeness of our sample, we recruited par-
ticipants from seven distinct geographical regions in China as
well as from urban and rural settings. Second, we focused
on the views of multiple stakeholders, while the actual feel-
ings from PLHIV may be more practicable. Third, the flexibil-
ity inherent in our inductive approach to generating themes
may lead to inconsistency and lack of coherence in identifying
themes [14]. We closely followed a six-step procedure in our
thematic analysis to maximize consistency and reproducibility
in our results [39]. Fourth, interviews were conducted dur-
ing the early phase of the COVID-19 outbreak in February
2020. Barriers to ART adherence and stakeholder responses
may have changed as the pandemic continued to evolve, and
these changes would not have been captured in this study.
Finally, significant differences exist between PLHIV and deliv-
ery of HIV care across countries and regions. The barriers and
solutions identified through our interviews may not be rele-
vant or applicable to other contexts.
5 CONCLUS IONS
We found CBO played an important role in ART mainte-
nance during the COVID-19 pandemic in China. Innovative
solutions implemented by Chinese CBO, including peer nav-
igation to refill ART and CBO-coordinated provision of ART
through mail or home delivery services, could be useful in
other regions of China as well as internationally. Expansion
of CBO services faces deep structural limitations in China,
which has prevented nongovernmental organizations in China
from taking on a larger role in providing HIV care [40].
Healthcare policymakers should recognize the important role
CBO have played in ensuring access to ART, particularly dur-
ing the COVID-19 pandemic, and further incorporate CBO
into the existing ART delivery mechanism. Further research
is needed to evaluate the long-term cost-effectiveness and
feasibility of continuing CBO solutions to ART interruption
after the COVID-19 pandemic has ended. Efforts to maintain
ART access during future public health emergencies should
leverage collaborations between stakeholders, with CBO play-
ing a crucial bridging role between government agencies and
PLHIV.
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